Treatment Goals for LDL-c to Reduce Cardiovascular Risk Depending on CV Risk Estimation*

Treatment Goals for LDL-c to Reduce Cardiovascular Risk Depending on CV Risk Estimation.png

Treatment algorithm for pharmacological low-density lipoprotein cholesterol lowering*

Adapted from: 2019 ESC/EAS Guidelines for the management of dyslipidaemia: lipid modification to reduce cardiovascular risk. Eur Heart J 2020 Jan 1;41(1):111-188.

SCORE2 and SCORE2-OP Cardiovascular disease risk estimation stratified by age*

CV risk estimation 

< 50y 

50-69y 

> 70y 

Low / moderate 

< 2.5% 

< 5% 

< 7.5% 

High 

2.5-<7.5% 

5-<10% 

7.5-<15% 

Very high 

> 7.5% 

> 10% 

> 15% 

* For the cardiovascular risk definitions, please refer to the 2019 ESC/EAS Guidelines for the management of dyslipidaemia: lipid modification to reduce cardiovascular risk.